An improved recombinant mammalian cell expression system for human transforming growth factor-β2 and -β3 preparations

Protein Expression and Purification

Volumn 50, Issue 1, 2006, Pages 9-17

  Zou, Zhongcheng ^a   Sun, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Activation; Chinese hamster ovary cell; LAP; LTBP; Protein expression; Purification; TGF 2; TGF 3

Indexed keywords

CALPAIN; CATHEPSIN D; GLYCOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; PLASMIN; RECOMBINANT PROTEIN; SIALIDASE; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHO CELL; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETICS; HAMSTER; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN BINDING; TIME;

ANIMALS; CALPAIN; CATHEPSIN D; CELL LINE; CELLS, CULTURED; CHO CELLS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; MANNOSYL-GLYCOPROTEIN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; NEURAMINIDASE; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PLASMIN; PROTEIN BINDING; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

CRICETULUS GRISEUS; MAMMALIA;

EID: 33750491297     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.06.022     Document Type: Article

References (31)

1. Huang X., and Lee C. From TGF-beta to cancer therapy. Curr. Drug Targets 4 (2003) 243-250
2. Govinden R., and Bhoola K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol. Ther. 98 (2003) 257-265
3. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16 (1998) 137-161
4. Burmester J.K., Qian S.W., Roberts A.B., Huang A., Amatayakul-Chantler S., Suardet L., Odartchenko N., Madri J.A., and Sporn M.B. Characterization of distinct functional domains of transforming growth factor beta. Proc. Natl. Acad. Sci. USA 90 (1993) 8628-8632
5. Olofsson A., Miyazono K., Kanzaki T., Colosetti P., Engstrom U., and Heldin C.H. Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J. Biol. Chem. 267 (1992) 19482-19488
6. Koli K., Saharinen J., Hyytiainen M., Penttinen C., and Keski-Oja J. Latency, activation, and binding proteins of TGF-beta. Microsc. Res. Tech. 52 (2001) 354-362
7. Miyazono K., Olofsson A., Colosetti P., and Heldin C.H. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 10 (1991) 1091-1101
8. Jennings J.C., and Mohan S. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins. Endocrinology 126 (1990) 1014-1021
9. Madisen L., Lioubin M.N., Marquardt H., and Purchio A.F. High-level expression of TGF-beta 2 and the TGF-beta 2(414) precursor in Chinese hamster ovary cells. Growth Factors 3 (1990) 129-138
10. Madisen L., Farrand A.L., Lioubin M.N., Marzowski J., Knox L.B., Webb N.R., Lim J., and Purchio A.F. Expression and characterization of recombinant TGF-beta 2 proteins produced in mammalian cells. DNA 8 (1989) 205-212
11. Graycar J.L., Miller D.A., Arrick B.A., Lyons R.M., Moses H.L., and Derynck R. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol. Endocrinol. 3 (1989) 1977-1986
12. ten Dijke P., Iwata K.K., Thorikay M., Schwedes J., Stewart A., and Pieler C. Molecular characterization of transforming growth factor type beta 3. Ann. N Y Acad. Sci. 593 (1990) 26-42
13. Gleizes P.E., Munger J.S., Nunes I., Harpel J.G., Mazzieri R., Noguera I., and Rifkin D.B. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 15 (1997) 190-197
14. Lawrence D.A. Transforming growth factor-beta: a general review. Eur. Cytokine Netw. 7 (1996) 363-374
15. Brown P.D., Wakefield L.M., Levinson A.D., and Sporn M.B. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3 (1990) 35-43
16. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., and Rifkin D.B. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 51 (1997) 1376-1382
17. Miyazono K., and Heldin C.H. Role for carbohydrate structures in TGF-beta 1 latency. Nature 338 (1989) 158-160
18. Lyons R.M., Keski-Oja J., and Moses H.L. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 106 (1988) 1659-1665
19. Abe M., Oda N., and Sato Y. Cell-associated activation of latent transforming growth factor-beta by calpain. J. Cell Physiol. 174 (1998) 186-193
20. Pedrozo H.A., Schwartz Z., Robinson M., Gomes R., Dean D.D., Bonewald L.F., and Boyan B.D. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Endocrinology 140 (1999) 5806-5816
21. Zou Z., and Sun P.D. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system. Protein Expr. Purif. 37 (2004) 265-272
22. Coloma M.J., Hastings A., Wims L.A., and Morrison S.L. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J. Immunol. Methods 152 (1992) 89-104
23. Ogawa Y., and Seyedin S.M. Purification of transforming growth factors beta 1 and beta 2 from bovine bone and cell culture assays. Methods Enzymol. 198 (1991) 317-327
24. Hodgson J. Expression systems: a user's guide. Emphasis has shifted from the vector construct to the host organism. Biotechnology (N Y) 11 (1993) 887-893
25. Stewart A.A., Haley J.D., Qu G.Y., Stam K., Fenyo D., Chait B.T., Marshak D.R., Ng A.Y., Marley G., and Iwata K.K. Umbilical cord transforming growth factor-beta 3: isolation, comparison with recombinant TGF-beta 3 and cellular localization. Growth Factors 13 (1996) 87-98
26. Arrick B.A., Lee A.L., Grendell R.L., and Derynck R. Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5′ untranslated region. Mol. Cell. Biol. 11 (1991) 4306-4313
27. Sano K., Maeda K., Oki M., and Maeda Y. Enhancement of protein expression in insect cells by a lobster tropomyosin cDNA leader sequence. FEBS Lett. 532 (2002) 143-146
28. Tan S., Wu W., Liu J., Kong Y., Pu Y., and Yuan R. Efficient expression and secretion of recombinant hirudin III in E. coli using the l-asparaginase II signal sequence. Protein Expr. Purif. 25 (2002) 430-436
29. Gentry L.E., Lioubin M.N., Purchio A.F., and Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol. Cell. Biol. 8 (1988) 4162-4168
30. De Crescenzo G., Grothe S., Zwaagstra J., Tsang M., and O'Connor-McCourt M.D. Real-time monitoring of the interactions of transforming growth factor-beta (TGF-beta) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. J. Biol. Chem. 276 (2001) 29632-29643
31. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6 (1990) 597-641